| 704268 |
FRONTIERS IN GENETICS |
Genotyping and Whole-Genome Resequencing of Welsh Sheep Breeds Reveal Candidate Genes and Variants for Adaptation to Local Environment and Socioeconomic Traits |
2021-06-18 |
10.3389/fgene.2021.612492 |
Sweet-Jones James, Lenis Vasileios Panagiotis, Yurchenko Andrey A., Yudin Nikolay S., Swain Martin, Larkin Denis M. |
| 704267 |
FRONTIERS IN GENETICS |
Comprehensive Analysis of lncRNA and miRNA Regulatory Network Reveals Potential Prognostic Non-coding RNA Involved in Breast Cancer Progression |
2021-06-18 |
10.3389/fgene.2021.621809 |
Gao Sheng, Lu Xun, Ma Jingjing, Zhou Qian, Tang RanRan, Fu Ziyi, Wang Fengliang, Lv Mingming, Lu Cheng |
| 704266 |
FRONTIERS IN ONCOLOGY |
Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma |
2021-06-18 |
10.3389/fonc.2021.657002 |
Liu Baoling, Su Quanping, Ma Jianhua, Chen Cheng, Wang Lijuan, Che Fengyuan, Heng Xueyuan |
| 704265 |
FRONTIERS IN ONCOLOGY |
Aspirin Use and Common Cancer Risk: A Meta-Analysis of Cohort Studies and Randomized Controlled Trials |
2021-06-18 |
10.3389/fonc.2021.690219 |
Wang Lijuan, Zhang Rongqi, Yu Lili, Xiao Jiarui, Zhou Xuan, Li Xinxuan, Song Peige, Li Xue |
| 704264 |
FRONTIERS IN ONCOLOGY |
Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure |
2021-06-18 |
10.3389/fonc.2021.687374 |
Hu Junxia, Wang Xin, Chen Fei, Ding Mengjie, Dong Meng, Yang Wanqiu, Yin Meifeng, Wu Jingjing, Zhang Lei, Fu Xiaorui, Sun Zhenchang, Li Ling, Wang Xinhua, Li Xin, Guo Shuangshuang, Zhang Dianbao, Lu Xiaohui, Leng Qing, Zhang Mingzhi, Zhu Linan, Zhang Xudong, Chen Qingjiang |
| 704263 |
FRONTIERS IN ONCOLOGY |
Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer |
2021-06-18 |
10.3389/fonc.2021.632387 |
Yan Xin, Wu Hua-Hui, Chen Zhao, Du Guo-Wei, Bai Xiao-Jie, Tuoheti Kurerban, Liu Tong-Zu |
| 704262 |
FRONTIERS IN ONCOLOGY |
Combined Inhibition of Akt and mTOR Is Effective Against Non-Hodgkin Lymphomas |
2021-06-18 |
10.3389/fonc.2021.670275 |
Rivera-Soto Ricardo, Yu Yi, Dittmer Dirk P., Damania Blossom |
| 704261 |
FRONTIERS IN ONCOLOGY |
GEFT Inhibits Autophagy and Apoptosis in Rhabdomyosarcoma via Activation of the Rac1/Cdc42-mTOR Signaling Pathway |
2021-06-18 |
10.3389/fonc.2021.656608 |
Li Chunsen, Li Zhenzhen, Song Lingxie, Meng Lian, Xu Guixuan, Zhang Haijun, Hu Jianming, Li Feng, Liu Chunxia |
| 704260 |
FRONTIERS IN ONCOLOGY |
Editorial: Novel Combination Therapies for the Treatment of Solid Cancers |
2021-06-18 |
10.3389/fonc.2021.708943 |
Ayoub Nehad M. |
| 704259 |
FRONTIERS IN ONCOLOGY |
Case Report: Nintedanib for Pembrolizumab-Related Pneumonitis in a Patient With Non-Small Cell Lung Cancer |
2021-06-18 |
10.3389/fonc.2021.673877 |
Xie Xiao-Hong, Deng Hai-Yi, Lin Xin-Qing, Wu Jian-Hui, Liu Ming, Xie Zhan-Hong, Qin Yin-Yin, Zhou Cheng-Zhi |
